Hepatitis C virus and type 2 diabetes - Wikidata - awgldk - TriplyDB

Hepatitis C virus and type 2 diabetes

Hepatitis C virus and type 2 diabetes

http://www.wikidata.org/entity/Q24658049

about

Hepatitis C virus as a systemic disease: reaching beyond the liver Epidemiology of hepatitis C virus in Iran Hepatitis C virus infection and type 1 and type 2 diabetes mellitus Autophagy in hepatitis C virus-host interactions: potential roles and therapeutic targets for liver-associated diseases Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Hepatitis C virus infection suppresses GLUT2 gene expression via downregulation of hepatocyte nuclear factor 1α.Molecular mechanism of hepatitis C virus-induced glucose metabolic disorders Association of Hepatitis C Virus Infection with Type II Diabetes in Ethiopia: A Hospital-Based Case-Control Study The association of hepatitis C virus infection and post-liver transplant diabetes: data from 17 000 HCV-infected transplant recipients.Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.The spectrum of cutaneous infection in diabetic patients with hepatitis C virus infection: a single-center study from egypt.Prevalence of type 2 diabetes in Algerian patients with hepatitis C virus infection Seroprevalence of hepatitis C in type 2 diabetes: evidence for a positive association.Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection Insulin resistance and chronic liver disease.Association of HCV with diabetes mellitus: an Egyptian case-control study.Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes.The Impact of Hepatitis B Vaccination Status on the Risk of Diabetes, Implicating Diabetes Risk Reduction by Successful Vaccination Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis.RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection Infections in patients with diabetes mellitus: A review of pathogenesis.Hepatitis C virus infection among patients with diabetes mellitus in Dammam, Saudi Arabia Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infection Association of hepatitis C with markers of hemostasis in HIV-infected and uninfected women in the women's interagency HIV study (WIHS).Prevalence of type 2 diabetes mellitus in hepatitis C virus infected population: a Southeast Asian study.Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways Retrospective study of the associations between hepatitis C virus infection and metabolic factors.Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies.Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus.Safety and efficacy of treatment for chronic hepatitis C with a focus on pegylated interferons: the backbone of therapy today and in the future.Steatosis and insulin resistance in response to treatment of chronic hepatitis C.Hepatitis C virus induced insulin resistance impairs response to anti viral therapy.Diabetes and infections-hepatitis C: is there type 2 diabetes excess in hepatitis C infection?Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review.The Role of Human Herpesvirus 8 in Diabetes Mellitus Type 2: State of the Art and a Medical Hypothesis.Impact of hepatitis C virus therapy on metabolism and public health.Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis.Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes.

P2860

Q26776387-5538E05A-9D8C-458A-8123-4449E4AD691E Q26781996-5FE74898-201A-482E-A755-B53814BA1580 Q26829202-A9A244F3-A55B-4453-9F26-82CD4C5212BB Q26992256-108D1B0D-062A-4EEA-A661-2CD817D3716D Q28728915-13F40458-160B-416E-86FE-963B8B996F9D Q30369757-6E3ADC97-766A-4C0D-8EBF-700FC74A734F Q30393729-5C12BEFC-F01E-49AF-B4D5-1A4A1933393D Q30395601-ACE58341-1AD1-4F31-A249-C68A3DAE4831 Q30422090-70738ECA-D8D1-4E4B-999B-0B55CB069F1B Q30870794-F7948889-A7BD-4139-9051-CE2E4724F68E Q33559091-B198B4C1-5FF7-4B48-9367-214BA9F9C697 Q33683510-173BDD77-977D-4B8B-8755-6E6A1F19EC77 Q33998662-F69C4B0D-2F7B-4B02-BE9A-D2B642438292 Q34351092-A2E6D873-2831-4177-86F7-0F49E5002AE7 Q34949587-F84B5D51-2870-4CEA-9404-4D1D17FE6F3B Q35073012-1E820642-68AE-4BEE-8D9E-43CB01DC5284 Q35427376-C6ABAD29-AC79-4900-AFF9-9CB0C478F8E9 Q35813414-545AF2C5-B840-4FDB-9DFA-9178B7BCAF80 Q35824137-92D804AB-2AE2-4DA0-BC1F-E187C25E20D3 Q35886690-326C2289-BED6-4D45-8C6E-D876A74B2A74 Q35943663-78FD78B8-7CD4-4877-9CB6-65193A8D0756 Q35968061-955B9D86-413A-4C13-B1A6-1A033072E855 Q36087671-AEA93DEB-97E0-4008-B50E-4FA500B32FF0 Q36298307-F296C0DA-7DF6-4C11-974C-93B564A513ED Q36335088-5C3292ED-AE5B-46F0-A966-2347DEE32F69 Q36840571-1E44BC4B-3E15-45FE-A836-6829620BC40F Q37105110-E1296491-3654-4AA1-B482-1191D9C85B7C Q37188890-6DA5933E-470D-4EAC-8EAD-2CD24448BF3D Q37374053-392A4945-0BBC-408B-8E3F-D620AE2A9281 Q37527686-A56970BF-1709-4912-A29D-BC753DB3F5A6 Q37713887-FA24F4FC-049B-472B-A5BC-B97893803557 Q37846232-53C28F1C-823B-441F-B962-421E0126276F Q37974700-32458BC4-5316-43E8-945B-F96747B09607 Q37980432-8425D42A-0B64-45AB-B243-740D6900731F Q38086739-01159E89-4B28-4774-AC9D-CECC63A937F4 Q38351750-A0D9AECF-7F7C-4D34-8A24-7DCC4622253E Q38626635-8C323C07-4D85-41B7-8BA2-D861121B8BBA Q39040729-29326159-4AEC-40C6-90A4-8911E66AF13C Q39556422-48FF9175-9CFD-4948-8E24-5F30E8A1ABD5 Q40240819-5A1E8965-6072-45C4-9B12-BD40B292E9F2

P2860

Hepatitis C virus and type 2 diabetes

http://www.wikidata.org/entity/Q24658049

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatitis C virus and type 2 diabetes

@ast

Hepatitis C virus and type 2 diabetes

@en

Hepatitis C virus and type 2 diabetes

@nl

type

label

Hepatitis C virus and type 2 diabetes

@ast

Hepatitis C virus and type 2 diabetes

@en

Hepatitis C virus and type 2 diabetes

@nl

prefLabel

Hepatitis C virus and type 2 diabetes

@ast

Hepatitis C virus and type 2 diabetes

@en

Hepatitis C virus and type 2 diabetes

@nl

P1433

Q24658049-CA06D9B3-D9F1-4B92-97FC-EC27A6D0D891

P1476

Q24658049-2CB686A1-D8EB-479D-95D7-218E11FD61A5

P2093

Q24658049-4C1A6A0A-0678-4A81-BD80-50A7052BEB56

Q24658049-8E09347B-4EFF-4079-B777-78CBE22D5D6B

P2860

Q24658049-008E7C51-9879-4218-8605-9DCAD10D1DBD

Q24658049-01285972-E1BC-4F1F-8CEC-190836F1EA43

Q24658049-02CBA5C0-A604-454A-AE41-BDAFCC642F33

Q24658049-031F1255-4233-4D0E-B8FC-491CE885B173

Q24658049-036592FE-6909-4237-9630-A92D13A608C4

Q24658049-0B59DB35-C83F-45DE-A657-DAFD250630AE

Q24658049-0BB42865-7EF2-474D-A5B6-E7ACBBD0DDD6

Q24658049-0C15CBAD-E023-4F74-A28F-5962FCBA76AC

Q24658049-0E1EE993-3112-49A0-AD17-78B892C56404

Q24658049-100F1497-1783-4834-95B8-618921CD942B

P304

Q24658049-7C4D0357-D4D3-4D2F-B917-C8DF4B882ED6

P31

Q24658049-29c5ebfe-da58-418c-992c-b46481804a16

Q24658049-A6FEF55E-BB10-422A-967C-8DF089685B80

P3181

Q24658049-FFDCA7E6-D3C1-4E5D-AA03-3C265107E9A9

P356

Q24658049-9966C98E-8BF7-499B-BF24-B52EF1A4DFB1

P407

Q24658049-DF79FF6D-3E37-46EC-AEB7-368DF3BD01ED

P433

Q24658049-89082BE2-3662-4DF9-A72A-807224258F7A

P478

Q24658049-E77E31F4-85ED-4A34-80BD-D87F73976546

P577

Q24658049-59F5BC53-74C5-49F3-87A5-590D1681EF8C

P698

Q24658049-8A706926-D51C-4036-A848-A54373ABC0A0

P921

Q24658049-2156C241-C4FC-4557-9517-4DB7EB37A465

Q24658049-7186D441-62CB-4256-9EFF-E448BD933A1E

P932

Q24658049-2EFB32EA-D3B0-4E88-A5E1-3D5FBF3FCB9D

P3181

P356

P1433

World Journal of Gastroenterology

P1476

Hepatitis C virus and type 2 diabetes

@en

P2093

Francesco Negro

http://www.w3.org/2001/XMLSchema#string

Mahnaz Alaei

http://www.w3.org/2001/XMLSchema#string

P2860

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

Molecular mediators of hepatic steatosis and liver injury

Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids

Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.

Signaling by type I and II cytokine receptors: ten years after.

Association of diabetes mellitus and chronic hepatitis C virus infection.

P304

1537-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1575709

http://www.w3.org/2001/XMLSchema#string

P356

10.3748/WJG.15.1537

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19340895

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2669937

http://www.w3.org/2001/XMLSchema#string